PROTAC antibody conjugates and methods of use
US11666581B2 · kind B2 · utility
0Cited by
2References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2018 |
| Grant date | Jun 6, 2023 |
| Priority date | — |
| Expiry date | Oct 2, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y203/02007
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject matter described herein is directed to antibody-PROTAC conjugates (PACs), to pharmaceutical compositions containing them, and to their use in treating diseases and conditions where targeted protein degradation is beneficial.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.